Major Pharmaceuticals: Levothyroxine Sodium Tablets, Usp, 75 Mcg (0.075 Mg), 100 Tablets (10 X 10 Unit Dose Blisters) Per Carton

Recall Summary Major Pharmaceuticals is recalling Levothyroxine Sodium Tablets 75 mcg (100-tablet packages) because the medication contains less active ingredient than it should. The affected product was distributed nationwide across all U.S. states and territories. Patients taking this medication who have the recalled batch should contact their healthcare provider or pharmacist.

Recalling firm

Major Pharmaceuticals

Product

Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6951-61

Reason

Subpotent Drug

Classification

Class II

Category

drug recall

Country

United States

Agency

U.S. Food and Drug Administration

Recall date

2026-07-13

Status

Ongoing

Areas affected

AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...

Distribution

Nationwide in the USA.

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/76b97e45-3911-425b-ae13-0799cdb267b5